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For major histocompatibility complex class I and II mole-
cules, the binding of specific peptide antigens is essential for
assembly and trafficking and is at the center of their quality
control mechanism. However, the role of lipid antigen binding
in stabilization and quality control of CD1 heavy chain (HC)2-
microglobulin (2m) complexes is unclear. Furthermore, the
distinct trafficking and loading routes of CD1 proteins take
them frommildly acidic pH in early endososmal compartments
(pH6.0) tomarkedly acidic pH in lysosomes (pH5.0) andback to
neutral pH of the cell surface (pH 7.4). Here, we present evi-
dence that the stability of each CD1 HC2m complex is deter-
mined by the distinct pH optima identical to that of the intra-
cellular compartments in which each CD1 isoform resides.
Although stable at acidic endosomal pH, complexes are only
stable at cell surface pH 7.4 when bound to specific lipid anti-
gens. The proposed model outlines a quality control program
that allows lipid exchange at low endosomal pH without disso-
ciationof theCD1HC2mcomplex and then stabilizes the anti-
gen-loaded complex at neutral pH at the cell surface.
CD1 molecules represent a distinct lineage of antigen-pre-
senting molecules that are related to major histocompatibility
complex (MHC)3 class I proteins sharing limited sequence sim-
ilarity and domain organization including a heavy chain (HC)
composed of 1, 2 and 3 domains associated non-covalently
with 2-microglobulin (2m). Despite these structural similar-
ities, CD1 proteins are functionally distinct because they bind
and present lipid antigens to elicit T cell-mediated immunity
(1). Lipid antigen binding is determined by the presence of deep
hydrophobic grooves in the1 and2 antigen binding domains
of the CD1 heavy chain. This topology buries the alkyl chains of
the antigens below theCD1 surface and exposes the hydrophilic
head groups at the CD1 surface, where moieties of the head
group and the CD1 -helices can be recognized by T cell anti-
gen receptors. The assembly of CD1 molecules takes place in
the endoplasmic reticulum (ER) with the participation of sev-
eral chaperones also involved in the formation of the MHC
class I peptide loading complex, namely calnexin, calreticulin,
and ERp57 (2). In the ER, newly synthesized CD1molecules are
thought to be loaded with self-lipid antigens after which they
traffic to the cell surface along the secretory pathway (3). From
the plasma membrane CD1 molecules are internalized and
recycle through the endocytic system where lipid antigens are
bound and exchanged (1). Human CD1a traffics mainly
through early endosomes and the early endocytic recycling
compartment where it co-localizes with MHC class I (4, 5). In
contrast, mouse (m) CD1d and human (h) CD1b are sorted
mainly to late endosomes and lysosomeswhere they co-localize
withMHC class II proteins (4, 6–8). HumanCD1c and to some
extent hCD1d are distributed more extensively in both early
and late endocytic compartments (9, 10).
For MHC class I molecules, the binding of specific peptide
antigens is essential to complete the assembly of these com-
plexes, regulate their exit from the ER and their integrity on the
cell surface. Indeed, in transporter associated with antigen pro-
cessing-deficient cells, which are unable to deliver peptides to
the ER, the stability ofMHCclass I heavy chain (HC)/2m com-
plexes is decreased and empty MHC class I proteins are
retained in the ER (11, 12). This process functions in part as a
quality control mechanism and protects the cell from expres-
sion of incompletely assembled or empty antigen-presenting
molecules. Similarly, the stability of MHC class II complexes is
ensured by the invariant chain (Ii), and the CLIP peptide is
replaced by peptide antigens that stabilize MHC class II /
heterodimers (13). However, it is unclear if CD1 molecules can
be stabilized by binding of specific lipid antigens. The ER-local-
ized microsomal triglyceride transfer protein has been impli-
cated in loading self-lipid antigen during assembling of CD1 in
the ER (14, 15). In an experimental system, the culture of CD1a
expressing cells under serum (lipid)-deficient conditions par-
tially reduces the surface expression of CD1a (16). These stud-
ies indirectly point to a protective effect of lipids on CD1 sta-
bility, but so far no studies have directly examined the effect of
lipid binding on stability of CD1 complexes. Furthermore, the
distinct trafficking and loading routes of CD1 proteins take
them frommarkedly acidic pH in lysosomes (pH 5.0) to neutral
pH of the cell surface (pH 7.4). Here, we show for the first time
that the stability of individual CD1HC2m complexes is deter-
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mined by a specific pH optimum identical to the intracellular
compartment to which the CD1 isoform localizes. Although
stable at their optimal intracellular pH, CD1 HC2m com-
plexes are only stable at neutral pHwhenboundby specific lipid
antigens. This model outlines a quality control program that
allows lipid binding/exchange at low pH where the CD1
HC2m heterodimer is stable even without bound lipid and
then specific lipid binding stabilizes the complex for expression
at the cell surface at neutral pH.
EXPERIMENTAL PROCEDURES
Lipids—-GalCer, -GalCer, and C32 glucose monomyco-
late (GMM) were synthesized by G. Besra as previously de-
scribed (30, 31). Trehalose monomycolate was isolated in this
laboratory from a polar lipid extract obtained from -irradiated
Mycobacterium tuberculosis (H37Rv, Colorado State Univer-
sity) according to the procedures of Dobson and co-workers
(32).
Antibodies—All antibodies used for immunoprecipitation of
CD1 and MHC class I and II molecules and their potential
cross-reactivity were described previously: anti-CD1a antibod-
ies: 10H3 (mouse, IgG2a) (33), OKT6 (mouse, IgG1) (34),
10D12 (mouse, IgG1) (33); anti-CD1b antibodies: BCD1b3
(mouse, IgG1) (35), BCD1b1 (mouse, IgG1) (36), 4A7.6 (mouse
IgG2a) (33); anti-CD1c antibody F10/21.3 (mouse, IgG1) (37);
anti-human CD1d antibodies: 42.1.1 (mouse, IgG1), 55.10
(mouse, IgG1), and 75.10 (mouse, IgG1) (17); anti-mouse CD1d
antibody 19G11 (rat, IgG2b/, kindly provided by A. Bendelac,
University of Chicago, Chicago, IL) (38); anti-human 2m Ab
BBM.1 (mouse, IgG1) (39); anti-MHC class I antibody W6/32
(mouse, IgG2a) (40); and anti-HLA-DR antibody L243 (mouse,
IgG2a) (39). Isotype control antibodies used for experiments
were: P3 antibody (mouse IgG1), murine myelomamonoclonal
IgG2a (Sigma), and rat isotype IgG2b (BD Biosciences).
CD1-transfected Cell Lines—Previously established cervical
carcinomaHeLa cell lines transfected with CD1a (5), CD1b (6),
CD1c (41), or CD1d (42) were used. Reagents for cell culture
were from Invitrogen.HeLa transfectants were cultured inDul-
becco’s modified Eagle’s medium containing heat-inactivated
10% fetal calf serum (Gemini Bio-Products), 100 units/ml of
penicillinG, 100g/ml of streptomycin, 2mM L-glutamine, and
20 mM HEPES with addition of 1.0 mg/ml of geneticin (G418).
The MHC class I-deficient B lymphoblastoid cell lines, C1R
transfected with CD1a, CD1b, CD1c (35, 43), and CD1d (17),
were also described previously. C1R cells were cultured in
RPMI with heat-inactivated 10% fetal calf serum, 100 units/ml
of penicillin G, 100 g/ml of streptomycin, 2 mM L-glutamine,
and 20 mM HEPES. The mouse CD1d-transfected RAW cell
line was derived in this laboratory by Dr. Manuela Cernadas.
Protein Labeling and Cell Lysis—HeLa, C1R, or RAW cells
(2  107) were biotinylated by adding of 10 ml of PBS with 20
mMHEPES (pH 8.0), containing Sulfo-NHS-LC-biotin (Pierce)
in a final 0.2 mg/ml concentration. Cells were incubated at 4 °C
for 30 or 10min at room temperature. To quench excess biotin,
the cells were incubated for 5 min with 10ml of 0.4 M glycine in
PBS at room temperature and thenwashed twicewith cold PBS.
Cells (107) were lysed with 2 ml of lysis buffer (0.5% Triton
X-100, 150 mM NaCl, 5 mM EDTA, and 25 mM Tris, pH 7.4,
or 50 mM sodium citrate adjusted to pH 7.4, 7.0, 6.5, 6.0, 5.5,
5.0, or 4.5). All buffers contained protease inhibitors (aproti-
nin, phenylmethylsulfonyl fluoride, antipain dihydrochloride,
chymostatin, leupeptin, pepstatin A, sodium orthovanadate,
and sodium fluoride; all from Sigma). After 30–45min of incu-
bation with lysis buffer at 4 °C, lysates were centrifuged
(13,000 g for 10 min at 4 °C) and the supernatants were col-
lected and incubated as described under “Results” and in the
figure legends.
Immunoprecipitation—Cell lysates (obtained from 5 105–
106 cells) were used for each immunoprecipitation (IP). CD1a
molecules were immunoprecipitated with monoclonal anti-
bodies (mAbs): 10H3 (1–2 g/sample), OKT6 (2–4 g/sam-
ple), or 10D12 (2–4 g/sample). CD1b molecules were precip-
itated with mAbs: BCD1b3.1 (1–2 g/sample), BCD1b1.1
(5–10 g/sample), or 4A7.3 (2–4 g/sample). CD1c immuno-
precipitation was performed with mAb F10/21A3 (1–4
g/sample). For IP of hCD1d:2m mAbs 42.1.1 (1–2 g/sam-
ple) or 55.1 (2–4 g/sample) were used, whereas mAb 75.10
(5–10 g/sample) was used for IP of free hCD1d heavy chain.
mCD1d was precipitated with rat mAb 19G11.2 (0.5–1.0
g/sample). MHC class I was immunoprecipitated with mAb
W6/32 (1–2 g/sample), 2m with mAb BBM.1 (1–5 g/sam-
ple), and MHC class II with mAb L243 (0.1–0.2 g/sample).
Equivalent amounts of P3 (mouse IgG1), murine myeloma
monoclonal IgG2a (Sigma), or rat isotype IgG2b (BD Bio-
sciences) were used as isotype controls. Lysates were incubated
with antibodies for 45–60 min on ice and then 20 to 25 l of
GammaBind G-Sepharose (GE Healthcare) were added. After
incubating overnight at 4 °C or alternatively 2–3 h with rota-
tion, the beads were washed three times with RIPA buffer (1%
Triton X-100, 0.1% SDS, 0.05% deoxycholate, 50 mM Tris, pH
7.4, 150 mMNaCl), then washed once with 50mMTris (pH 6.8)
and resuspended in SDS sample buffer (62.5 mM Tris, pH 6.8,
10% glycerol, 2% SDS, 0.025% bromphenol blue, and 179 mM
-mercaptoethanol).
Electrophoresis, Immunoblotting, and Protein Detection—
Samples were loaded on 15% acrylamide SDS-PAGE and run in
a Protean XL apparatus (Bio-Rad) with constant current (50
mAmp per gel). After electrophoresis, proteins were trans-
ferred to polyvinylidene fluoride membranes in transfer buffer
(25 mM Tris, 192 mM glycine, and 10% methanol) at 25 V over-
night in a Trans-Blot Cell (Bio-Rad). After transfer,membranes
were blocked with 0.2% Tween 20 in PBS (PBST) and 0.5%
bovine serum albumin at room temperature for 1 h, incubated
with HRP-conjugated streptavidin (ExtrAvidin, 1:20 000;
Sigma;) in PBST for 45min, washed with PBST, and finally blots
were developed with Western Lightning Chemiluminescence
Reagent (Perkin Elmer) according to the manufacturer’s
instructions. The intensity of bands was measured by densi-
tometry using ImageJ software.
RESULTS
CD1 Proteins Are Less Stable at the Cell Surface Than MHC
Class I and IIMolecules—We first analyzed the stability of CD1
HC2m complexes in comparison to MHC class I and II com-
plexes. First, we examined CD1a and CD1b because they differ
markedly in the structure of their antigen binding grooves and
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are localized to different intracellular compartments. Cell sur-
face CD1 molecules were labeled with biotin and cells were
lysed with 0.5% Triton X-100 (pH 7.4). We performed IP of
CD1a:HeLa cell transfectant cell lysates incubated at 4 or 37 °C.
Incubation of lysates at 37 °C for
even 2 h dramatically reduced the
levels of CD1a HC2m complexes
immunoprecipitated when com-
pared with incubation at 4 °C. This
was observed when we used three
different conformation-specific an-
tibodies that recognize the CD1a
HC2m complex, but not the free
CD1a HC without 2m (Fig. 1A,
compare lanes 2–4 versus 6–8, and
note the loss of both CD1a HC and
2m). These results showing disso-
ciation of the CD1a HC2m com-
plex at 37 °C indicate the complex is
unstable under these experimental
conditions.
Next, we examined the stability
of the CD1b HC2m complex un-
der similar conditions. It also dis-
sociates at 37 °C, but with slower
kinetics than CD1a, requiring at
least 12–24 h after cell lysis (Fig.
1B, lane 2 versus 5, note the nearly
complete disappearance of CD1b
HC and 2m). As a control, under
these same conditions no detectable
change in quantity of MHC I
HC2m complexes was found (Fig.
1B, lane 3 versus 6). We also com-
pared the stability of CD1b with
MHC class II in CD1b-transfected
C1R cells and found that as in the
case of MHC class I, the MHC class
II heterodimerwas also stable under
these conditions (Fig. 1C, lanes 5
versus 10). The instability of CD1b
was confirmed using a separate
panel of conformation-dependent
anti-CD1b HC 2 mAb (BCD1b.1
and BCD1b3) (Fig. 1C, lanes 2 and
3 versus 7 and 8, respectively) and
mAb 4A7.6 (data not shown). To
complement the analysis using
CD1 HC2m conformation-de-
pendent mAb, next we used anti-
2mmAb BBM.1, which recognizes
2mwhether free or bound to CD1/
MHC I heavy chains. In C1R cells,
MHC I is essentially absent so that
on this cell line the mAb recognizes
only free or CD1 bound 2m. Strik-
ingly, mAb BBM.1 confirmed the
reduced stability of the CD1b
HC2mcomplex at 37 °C comparedwith 4 °C as the quantity of
co-immunoprecipitated CD1b HC was markedly reduced at
37 °C, whereas the total amount of 2m was comparable (Fig.
1C, lane 4 versus 9). The difference noted between lanes where
FIGURE1.CD1HC2mcomplexesareunstableat37 °C.CD1-transfectedHeLa cells orC1Rcellswere surface
bioyinylated, lysed with 0.5% Triton X-100 at pH 7.4, and lysates were incubated for 2–24 h at 4 or 37 °C. After
immunoprecipitation with specific anti-CD1, anti-MHC class I or II, and anti-2m antibodies, the immunopre-
cipitateswere analyzed by SDS-PAGE (15%) under reducing conditions and immunoblottedwith streptavidin-
HRP. A, HeLa:CD1a cell lysates were incubated at 4 (lanes 1–4) or 37 °C (lanes 5–8) for 2 h. CD1a:HC2m
complexes were immunoprecipitated with anti-CD1a 10H3 (lanes 2 and 6, solid line arrows), OKT6 (lanes 3 and
7, dotted line arrows), and 10D12 (lanes 4 and 8, dashed line arrows) antibodies. B, HeLa:CD1b cell lysates were
incubated at 4 (lanes 1–3) or 37 °C (lanes 4–6) for 24 h. CD1b:HC2m complexes were immunoprecipitated
with anti-CD1b BCD1.3 antibody (lanes 2 and 5) and MHC class I with W6/32 antibody (lanes 3 and 6). As a
control, mouse IgG1was used (isotype). C, C1R:CD1b cell lysates were incubated at 4 (lanes 1–5) or 37 °C (lanes
6–10) for 12 h. CD1b:HC2m complexes were immunoprecipitated with anti-CD1b BCD1b.3 (lanes 2 and 7,
solid line arrows), anti-CD1b BCD1b.1 (lanes 3 and 8, dotted line arrows) antibodies, anti-2m antibody BBM.1
(lanes 4 and 9, dashed line arrows), andMHC class II with anti-MHC II antibody L243 (lanes 5 and 10). As a control
mouse IgG1 was used (isotype). D, HeLa:CD1d cell lysates were incubated at 4 (lanes 1–5) or 37 °C (lanes 6–10)
for 2 h. CD1dHC2m complexeswere immunoprecipitatedwith anti-CD1d 42.1 (lanes 2 and 7, solid line arrow)
or 55.10 antibodies (lanes 3 and 8, dashed line arrows); free CD1d HC was immunoprecipitated with 75.10
antibody (lanes 4 and 9, dotted line arrows) and MHC class I with antibodyW6/32 (lanes 5 and 10). E, C1R:CD1d
cell lysates were incubated at 4 (lanes 1–5) or 37 °C (lanes 6–10) for 2 h. CD1d HC2m complexes were immu-
noprecipitated with anti-CD1d 42.1 (lanes 2 and 7, solid line arrows) or anti-2m BBM.1 antibodies (lanes 4 and
9, dashed line arrows); free CD1d HCwith anti-CD1d antibody 75.10 (lanes 4 and 9, dotted line arrows) andMHC
class II with anti-MHC II L243 antibody (lanes 5 and 10). In all experiments mouse IgG2a or IgG1 were used as
isotype controls. Arrows indicate the lanes to compare.
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CD1b HC2m complexes were immunoprecipitated with
anti-CD1b antibodies versus lanes precipitated with 2m-
specific antibody indicates that the antibodies recognize
slightly different pools of molecules. However, in every case
the mAb revealed a similar pattern of HC2m instability at
37 °C (Fig. 1, A–C).
Next, we analyzed the stability of CD1d using three different
anti-hCD1d mAb (42.1, 55.1, and 75.10) that allowed us to dis-
tinguish the free CD1d HC from the CD1d HC2m complex.
mAb 42.1 is conformation-dependent and recognizes only
CD1d HC2m complexes, whereas mAb 75.10 selectively
binds the free CD1d HC (17). mAb 55.1 recognizes both pools
of molecules under different conditions because it recognizes
theCD1dHC2mcomplex (by IP), but it can also recognize the
free CD1d HC (by Western blotting, data not shown). In
accordance with the results obtained for CD1a and CD1b, we
observed a reduction in immunoprecipitated CD1d HC2m
complexes and an increase in free CD1d HC in lysates incu-
bated for 2 h at 37 °C (Fig. 1, D and E). When anti-CD1d 42.1
mAb was used we saw a significant reduction of signal for the
CD1dHCboth inHeLa:CD1d andC1R:CD1d transfectant cells
(Fig. 1D, lane 2 versus 7). When the IP was performed with
anti-CD1d 55.1, which recognizes CD1d HC in a conforma-
tion-independent manner, we observed a decrease in the 2m
signal at 37 °Cbut no change in the signal forCD1dHC (Fig. 1D,
lane 3 versus 8). This suggests that the CD1d HC2m complex
disassembles without degradation of the HC. If true, then the
proportion of free CD1d HC should increase. This prediction
was confirmed by noting the significant increase in free CD1d
HC signal by IPwhenwe used anti-CD1d freeHC-specificmAb
75.10 in samples incubated 37 °C (Fig. 1D, lanes 4 versus 9). In
fact, the results obtained with anti-2m BBM1 mAb were also
consistent with this interpretation, because the CD1d HC sig-
nal decreased, although no change in the 2m signal was noted
after incubating cell lysates for 2 h at 37 °C (Fig. 1E, lanes 4
versus 9). Importantly, signals for MHC class I and II were rel-
atively unchanged under these same experimental conditions
(Fig. 1, E, lanes 5 versus 10 and D, lanes 5 versus 10) although
MHC I-associated 2m labeled only weakly, therefore limiting
its analysis in this experiment. Together, these data outline con-
ditions under which CD1 molecules labeled at the cell surface
dissociate after lysis in 0.5% Triton X-100 at 37 °C compared
with MHC I and II molecules under the same conditions.
The different times required for disassembly of CD1a
HC2m compared with CD1b HC2m complexes at 37 °C
suggests that each CD1 isoform may vary in its stability. To
address this possibility, we used HeLa cells transfected with
different CD1 proteins. As shown in Fig. 2A, CD1a displayed
the lowest stability after 2 h at 37 °Cwith over 95% dissociation,
followed by CD1d (75%) and CD1c (50%) (Fig. 2, D and C,
respectively). CD1b was the most stabile CD1 isoform, with
only 10% dissociation after 2 h at 37 °C (Fig. 2B). We also con-
firmed that MHC class I is very stable, showing no significant
reduction in signal after 2 h at 37 °C (Fig. 2, A–D).
FIGURE 2. Rank order of CD1 isoform stability: CD1b> CD1c> CD1d> CD1a. HeLa:CD1a, CD1b, CD1c, or CD1d transfectants were surface biotinylated,
lysed with 0.5% Triton X-100 (pH 7.4), and then lysates were incubated for 2 h at 4 or 37 °C. CD1 heavy chain/2m complexes were immunoprecipitated with
10H3 (anti-CD1a, A), BCD1b.3 (anti-CD1b, B), F10/23.A.1 (anti-CD1c, C), or 42.1 (anti-CD1d, D) antibodies, whereas MHC class I:HC2m complexes were
precipitated with antibody W6/32 (A–D). Mouse IgG1 and IgG2a were used as isotype controls. Immunoprecipitates were analyzed by SDS-PAGE (15%) in
reducing conditions and immunoblotted with streptavidin-HRP. Arrows indicate lanes to compare. Quantification of band intensity was measured by densi-
tometry using ImageJ software and results were calculated as proportion of HC or 2m signals at 37 °C compared with HC or 2m signals at 4 °C (A–D).
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Stabilization of CD1a and CD1b HC2M Complexes by Low
pH—Following biosynthesis in the ER and delivery to the
plasma membrane, CD1 proteins are then internalized to sur-
vey endocytic compartments for lipid antigens. CD1a and
CD1b are exposed to different environments because CD1a
localizes to the endocytic recycling
pathway (pH  6), whereas CD1b
localizes to lysosomes (pH below
5.5). To investigate if pH influences
CD1 stability, CD1-transfected HeLa
cells were lysed in 0.5% Triton
X-100 at pH 7.4 or 5.5 and then
incubated at 37 °C for various times.
As expected, incubation for 24 h at
37 °C at pH 7.4 resulted in signifi-
cant CD1b HC2m complex disas-
sembly (Fig. 3A, lane 2 versus 5).
Surprisingly, when lysis was per-
formed at pH 5.5 the complex was
markedlymore stable than at pH 7.4
with CD1b HC 30 versus 90% and
2m 50 versus 100% of signal de-
tected at pH 7.4 versus 5.5 (Fig. 3, A
lane 8 versus 11). Similar results
were also obtained using two other
anti-CD1bmAb, 4A7.6 and BCD1b.1
(not shown). In striking contrast to
CD1b stability at acidic pH, theMHC
class I HC 2m complex was much
less stable at pH 5.5 (Fig. 3A, lane 9
versus 12). Thus, CD1b HC 2m
complex stability is greater in lowpH,
whereas the opposite is true for the
MHC class I HC 2m.
In a similar way, we found that
low pH also protects CD1a HC2m
complexes from disassembling dur-
ing a period of 2 h at 37 °C (Fig. 3B,
lane 2 versus 5 and 8 versus 11).
Incubation of lysates at pH 7.4
markedly decreased the signal of
immunoprecipitated CD1a HC
2m complexes (reduction over
95%), whereas incubation at pH 5.5
partially protected CD1a from dis-
assembly (reduction of 50–60%).
The same result was also obtained
using two other anti-CD1a mAb,
10D12 and OKT6 (not shown).
In contrast to CD1a and CD1b,
very little if any protection from dis-
assembly was found at pH 5.5 for
human CD1d HC2m complexes
(Fig. 3C, lane 2 versus 5 and 8 versus
11). Consistent with disassembly of
the complex, we simultaneously de-
tected an increase in free CD1d HC
immunoprecipitatedwithmAb 75.10
(Fig. 3C, lane 3 versus 6 and 9 versus 12). pH does not affect anti-
body binding efficiency because the amount of immunoprecipi-
tatedCD1 andMHCclass I was similar at 4 °C (Fig. 3,A–D). Also,
an additional background band at75 kDa was noted in the iso-
type control at 37 °C (pH 7.4) in this experiment (Fig. 3C, lane 4).
FIGURE 3. Stabilization of CD1a and -b HC2m complexes by low pH. CD1-transfected HeLa cells were
surface biotinylated and lysedwith 0.5% Triton X-100 (pH 7.4 or 5.5). Then lysates were incubated for 2–24 h at
4 or 37 °C. After immunoprecipitation with specific anti-CD1 and anti-MHC class I antibodies, immunoprecipi-
tates were analyzed by SDS-PAGE (15%) in reducing conditions and immunoblotted with streptavidin-HRP.
A,HeLa:CD1bcell lysates atpH7.4 (lanes 1–6) or 5.5 (lanes 7–12)were incubatedat 4 (lanes 1–3and7–9) or 37 °C
(lanes 4–6 and10–12) for 24h. CD1b:HC2mcomplexeswere immunoprecipitatedwith BCD1b.3 (lanes 2, 5, 8,
and 11, solid line arrows) andMHCclass I:HC2mcomplexeswithW6/32 antibodies (lanes 3, 6, 9, and 12,dashed
line arrows). B,HeLa:CD1a cell lysates at pH 7.4 (lanes 1–6) or 5.5 (lanes 7–12) were incubated at 4 (lanes 1–3 and
7–9) or 37 °C (lanes 4–6 and 10–12) for 2 h. CD1a:HC2m complexes were immunoprecipitated with 10H3
(lanes 2, 5, 8, and 11, solid lines arrows) andMHC class I:HC2m complexes withW6/32 antibodies (lanes 3, 6, 9,
and 12, dashed line arrows). C,HeLa:CD1d cell lysates at pH 7.4 (lanes 1–6) or 5.5 (lanes 7–12) were incubated at
4 °C (lanes 1–3 and 7–9) or 37 °C (lanes 4–6 and 10–12) for 2 h. CD1d:HC2m complexes were immunoprecipi-
tatedwithmAb42.10 (lanes 2, 5, 8, and 11, solid line arrows) and the freeCD1dHCwasdetectedwithmAb75.10
(lanes 3, 6, 9, and 12,dotted line arrows).D,HeLa:CD1b cell lysates at pH5.5were incubated at 4 °C for 12h (lanes
1–3) or 37 °C for 12 (lanes 4–6) or 3 h followed by pH neutralization to pH 7.4 with 1.5 M Tris-HCl buffer (pH 8.8)
anda further 9-h incubationat 37 °C (lanes 7–9). CD1bHC2mcomplexeswere immunoprecipitatedwithmAb
BCD1b.3 (lanes 2, 5, and 8, solid line arrows) and MHC class I with mAb W6/32 (lanes 3, 6, and 9, dashed line
arrows). In all experiments isotype-matchedmouse IgG2a or IgG1were used as controls. Arrows indicate lanes
to compare.
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Given that internalization followed by recycling from
endocytic compartments would expose CD1 molecules to
higher and lower pH in sequence, we next determined if the
protective effect of low pH on CD1 stability is permanent or
is reversed by pH neutralization. Thus, we lysed CD1b-trans-
fected HeLa cells in pH 5.5 buffer, incubated the lysates for
3 h at 37 °C, and then rapidly neutralized the cells to pH 7.4.
Then, after further incubation at 37 °C (pH 7.4) for 9 h, we
immunoprecipitated CD1b and MHC class I with specific
mAb. As a control, we analyzed samples incubated at 4 or
37 °C for 12 h, without the neutralization step. The incuba-
tion of lysates in low pH for 3 h followed by 9 h at neutral pH
revealed instability of CD1b HC2m complexes (about 85%
reduction of CD1b HC) when compared with lysates incu-
bated at low pH throughout the experiment (Fig. 3D, lane 2
versus 8). These results suggest that the effect of pH on sta-
bility of the CD1 HC2m complex is reversible and does not
cause a permanent change in protein structure. In summary,
the evidence suggests that pH 5.5 markedly stabilizes of
CD1a and CD1b HC2m complexes but does not have a
significant influence on CD1d. This pH-dependent protec-
tive effect is reversible.
pH-dependent Protection of CD1Molecules Corresponds with
Their Locations in Intracellular Compartments—Given the
protection of CD1a and CD1b HC2m complexes noted at pH
5.5, we tested a range of pH to determine the optimum for
stability of each CD1 isoform.We lysed cells at pH 7.4, 7.0, 6.5,
6.0, 5.5, 5.0, or 4.5 and then incubated lysates at 4 or 37 °C for
different times. This pH range was selected to cover the typical
pH encountered at the plasma membrane (pH 7.4) or in the
early endosomes (pH 6.0) and lysosomes (pH 5.5) where CD1
isoforms traffic.
Remarkably, each CD1 isoform displayed a different opti-
mum pH for stability (Fig. 4, A–C). A maximum protective
effect for CD1a was achieved at pH 6.0, with some protection
occurring also at pH 5.5. In the case of the CD1bHC2m com-
plex, a broader range of protection from disassembling by pH
was observedwithmaximal protection seen at a pHbetween 5.0
and 5.5. CD1c achieves the maximum stability at pH 6.5 with a
second peak of protection at pH 5.0 and 5.5 (Fig. 4, A and B).
These results confirm that low pH stabilizes CD1a, -b, and -c
HC2m complexes from disassembly at 37 °C. Strikingly, the
maximum protection for each CD1 isoform is equivalent to the
pHof the intracellular compartment where that particular CD1
FIGURE 4. pH-dependent protection of CD1 molecules corresponds to their locations in intracellular compartments. HeLa:CD1a, -CD1b, -CD1c, and
-CD1d transfectants were surface biotinylated and lysed with 0.5% Triton X-100 at pH 7.4, 7.0, 6.5, 6.0, 5.5, 5.0, or 4.5. Lysates were incubated for 2 (CD1a and
CD1d), 12 (CD1c), or 24 h (CD1b) at 37 °C. CD1 heavy chain2m complexes were immunoprecipitated with 10H3 (CD1a), BCD1b.3 (CD1b), F10/23.A.1 (CD1c),
42.1 or 75.10 (CD1d) antibodies. Immunoprecipitates were analyzed by SDS-PAGE (15%) in reducing conditions and immunoblotted with streptavidin-HRP.
A, immunoprecipitated CD1 HC and 2m from lysates incubated at 37 °C at the indicated pH. B, quantification of band intensities for particular CD1 HC at
different pH values by densitometry using ImageJ software. Curves indicate the ratio of signal for CD1 HC in lysates incubated at 37 °C at different pH in
comparison to the incubation at 4 °C. C, the schematic shows the physiological pH of different intracellular compartments (ovals; ERC, endocytic recycling
compartment; EE, early endosomes; LE, late endosomes), the intracellular location of CD1a, CD1b, and CD1c (black bars), and maximal protective effect of pH
on the stability of CD1:HC2m complexes (gray triangles).
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molecule localizes physiologically. CD1a, which localizes to
early recycling endosomes that are typically between of pH 6.0
and 6.5, achieves its maximum protection in pH 6.0. CD1b,
which localizes to lysosomes, shows maximum protection at
pH 5 to 5.5. Remarkably, CD1c, which is broadly distributed
from early to late endosomes and lysosomes, shows significant
protection across a broader pH range than the other CD1
isoforms.
To further test the hypothesis that each CD1 isoform is
most stable at the pH of its steady state endosomal localiza-
tion site, we compared the pH dependence of human (h) and
mouse (m) CD1d HC2m complex stability. As noted above,
the effect of pH on hCD1d was distinct compared with that
observed for the group I CD1 molecules. Human CD1d only
partially localizes to LAMP-1 compartments (18), whereas
mouse CD1d strongly associates with AP3 (7, 8) and pre-
dominantly localizes to LAMP-1 compartments (19). Thus
mCD1d is more similar in steady state localization to hCD1b
than hCD1d. To examine the effect of pH on hCD1d and
mCD1d HC2m complex stability, we used hCD1d-trans-
fected HeLa cells and mCD1d-transfected RAW cells. First,
we found that mCD1d is more stable after cell lysis than
hCD1d, requiring at least 12 h for a significant reduction in
the signal of the HC2m complex (Fig. 5, A versus B). This
higher stability of mCD1d is also more similar to CD1b than
hCD1d. When we incubated lysates from CD1d-transfected
cells at different pH at 37 °C (Fig. 5 and data not shown), we
found pH-dependent protection from disassembly for both
human and mouse CD1d HC2m complexes. However, the
pH that protects mCD1d was significantly lower than in the
case of hCD1d and closer to CD1b (Fig. 5). The effect of pH
on the stability of hCD1d was less dramatic than observed in
the case of the humanCD1a, -b, and -c isoforms (Figs. 5Aversus
4), but nevertheless, the hCD1 HC2m complex was still more
stable at endosomal pH (between 6.5 and 6.0) than at neutral
pH. Thus, the pH at which each CD1 isoformHC2m complex
is protected from disassembly remarkably corresponds to the
pH of the compartment where each isoform is predominantly
localized in the cell at steady state.
CD1 HC2M Complexes Are Stabilized by Specific Lipid
Antigens—Amajor factor in the stability of MHC molecules is
peptide binding. In fact, in the absence of high affinity binding
peptides, MHC class I and II heterodimers either fail to com-
plete folding and/or are prone to dissociate. To study the pos-
sible role of specific lipid antigens in the stabilization of CD1
HC2m complexes we determined if -galactosylceramide
(-GalCer) could protect hCD1d from disassembling at 37 °C.
Eighty percent of the hCD1d HC2m complexes disassemble
when the lysates are incubated at 37 °C (pH7.4) for 2 h (see Figs.
1 and 2) and in this experiment over 95% dissociation occurred
(Fig. 6A, compare 2m in lanes 2 versus 6). To determine
whether -GalCer can protect CD1d HC2m complexes from
disassembly, we lysed CD1d-transfected HeLa cells and incu-
bated the lysates at 4 or 37 °C for 2 h at pH 7.4 in the presence or
absence of -GalCer. The addition of -GalCer to the lysates
during incubation at 37 °C markedly stabilized the CD1d
FIGURE 5. Effect of low pH on stability of human and mouse CD1d. HeLa:hCD1d and RAW:mCD1d transfectants were surface biotinylated and lysed with
0.5% Triton X-100 at pH 7.4, 7.0, 6.5, 6.0, 5.5, 5.0, or 4.5. Lysates were incubated for 2 h (hCD1d) or 2, 6, and 12 h (mCD1d) at 4 or 37 °C. Human CD1d:HC2m
complexeswere immunoprecipitatedwith anti-CD1dmAb42.1 and75.10,whereasmouseCD1d:HC2mcomplexeswere immunoprecipitatedwith antibody
19G11. Immunoprecipitates were analyzed by SDS-PAGE (15%) in reducing conditions and immunoblotted with streptavidin-HRP. A and B, immunoprecipi-
tated hCD1d andmCD1d HC and 2m from lysates incubated at 37 °C at the indicated pH. C, quantification of CD1d HC band intensities at different pH values
by densitometry using ImageJ software. Curves indicate the ratio of signal for CD1dHC in lysates incubated at 37 °C at different pH values in comparison to the
incubation at 4 °C.
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HC2m complexes immunoprecipitated by conformation-de-
pendent mAb 42.1 (Fig. 6A, lane 6 versus 22). Importantly, this
effect was dose-dependent and -GalCer had a greater effect at
higher concentrations (Fig. 6A, lanes 10, 14, 18, and 22). Con-
sistent with this conclusion, the incubation with -GalCer
reduced the quantity of free CD1d HC as detected by IP with
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mAb 75.10 (Fig. 6A, compare lane 7 with lanes 11, 15, 19, and
23). In contrast, the addition of-GalCer hadno effect onMHC
class I HC2m complex stability (Fig. 6A, compare lane 8 ver-
sus lanes 12, 16, 20, and 24). The quantification of CD1d
HC2m complex (42.1 mAb) and free CD1d HC (75.10 mAb)
underscores the protective effect of -GalCer on CD1d
HC2m disassembly as shown in Fig. 6B. In samples incubated
without or with low concentrations of -GalCer, the ratio of
CD1d HC2m complex to free CD1d HC is lower than 0.7,
whereas this ratio increases progressively with rising concen-
trations of lipid antigen until it reaches a value of 1.47 at 50
g/ml of -GalCer (Fig. 6B). Similar results were obtained with
C1R:CD1d transfectants (supplemental Fig. S1). It should be
noted that protection from dissociation of the CD1d HC2m
complex was not complete, even at the highest concentrations
of -GalCer tested (100 g/ml) (Fig. 6B and data not shown).
This could be due to the incomplete ability of -GalCer to pre-
vent HC2m dissociation or perhaps more likely insufficient
loading under our experimental conditions. Nevertheless, the
data strongly indicates that dose-dependent binding of a spe-
cific lipid antigen protects the CD1d HC2m complex from
disassembling.
Next, we sought to determine whether specificity of the lipid
was important in CD1d complex stability. It was possible that
stabilization of CD1d seen with -GalCer results from a non-
specific effect of lipid that is not related to specific binding of
-GalCer to CD1d. To examine this, we tested the effect of C80
trehalose monomycolate because it is predicted to be too long
to pack into the hCD1dbinding groves (20). First, we confirmed
CD1dHC2m complex stabilization at 37 °C in the presence of
-GalCer in a dose-dependent manner (supplemental Fig. S2).
In contrast, trehalose monomycolate had no effect across a
broad concentration range on CD1dHC2m complex stability
(supplemental Fig. S2D). This result supports the specific sta-
bilization of the CD1d HC2m complex by -GalCer.
Next, we further confirmed the role of lipid antigen binding
on stability of a second CD1 isoform, CD1b, and evaluated how
the dual factors, pH and lipid antigen binding, might cooperate
in stabilizing this HC2m complex.We tested if C32 (GMM), a
CD1b-presented antigen isolated from M. tuberculosis, could
stabilize CD1b molecules. We surface biotinylated CD1b-
transfectedC1R cells, lysed them in 0.5%TritonX-100 adjusted
to pH 5.5, and incubated the cells at 37 °C for 15 h in the pres-
ence or absence of C32 GMM, in increasing concentrations.
This first incubation was performed at pH 5.5 as this pH favors
lipid exchange (21) and we also showed this pH stabilizes the
CD1bHC2m complex. After a 3-h incubation at 37 °C, the pH
of samples was then neutralized and the lysates were incubated
for another 12 h at 37 °C, and stability of the CD1b HC2m
complexes was assessed by quantitating the CD1b HC that was
co-immunoprecipitated with anti-2m-specific mAb BBM.1.
In addition, similar aliquots of lysate were incubated at 4 °C as
baseline controls for the 37 °C sample (Fig. 6, C and D). Con-
firming the previous result, we found that the CD1b HC signal
was reduced in samples incubated at 37 °C compared with 4 °C
at neutral pH (Fig. 6C, compare lane 1 versus 2). Furthermore,
samples maintained at acidic pH 5.5 were also stable even at
37 °C (Fig. 6C, lane 5). Importantly, we found that addition of
GMM to the cell lysates substantially protected the CD1b
HC2m complexes from disassembly when the pH was raised
to 7.4 (Fig. 6C, lane 6 versus 7–12) and this protective effect was
dose-dependent (Fig. 6D). In contrast, incubation of lysates
with equivalent concentrations of -GalCer did not alter the
stability of the CD1b HC2m complex (supplemental Fig. S3).
Together these results show that the loading of specific lipid
antigens, such as C32 GMM, stabilizes the CD1b complex in a
manner similar to the protection of the CD1d complex by
-GalCer. It suggests amodel for the sequence of events during
CD1 intracellular trafficking (Fig. 7). We propose that when
CD1molecules localize to the endocytic compartment inwhich
they survey lipids, the CD1 HC2m complex is stabilized by
endosomal or lysosomal pH. This low pH-mediated stabiliza-
tion of the CD1HC2m complex allowsHC2m complexes to
remain intact during lipid exchange when the groove might be
temporarily empty. Then, when properly loadedwith an appro-
priate lipid antigen, the CD1 HC2m complex traffics to the
cell surface. At the cell surface, CD1 complexes encounter neu-
tral pH but no longer require low pH stabilization because the
presence of lipid in the binding groove provides stability at neu-
tral pH. This model also supports a potential quality control
mechanism in which CD1HC2m complexes without stabiliz-
ing lipid antigens that reach the cell surface are prone to disso-
ciate and have a shortened half-life (Fig. 7).
DISCUSSION
For both MHC class I and II, the binding of high affinity
peptides completes assembly and favors expression of the most
stable MHC complexes on the cell surface (22) and increases
FIGURE 6. Specific lipid antigens protect CD1d andCD1bHC2m complexes fromdisassembly. A,CD1d-transfectedHeLa cells were surface biotinylated
and lysed with 0.5% Triton X-100 (pH 7.4). Lysates were incubated for 2 h at 4 (lanes 1–4) or 37 °C (lanes 5–24) with different concentrations of -GalCer (lanes
9–24) or without lipid (lanes 1–8). CD1dHC2m complexeswere immunoprecipitatedwith anti-CD1dmAb 42.1 (lanes 2, 6, 10, 14, 18, and 22; solid line arrows),
free CD1dHCwere precipitatedwithmAb75.10 (lanes 3, 7, 11, 15, 19, and 23; dashed line arrows), andMHC class I with antibodyW6/32 (lanes 4, 8, 12, 16, 20, and
24). Mouse IgG1 and IgG2a were used as isotype controls. Immunoprecipitates were analyzed by SDS-PAGE (15%) under reducing conditions and immuno-
blottedwith streptavidin-HRP. B, quantification of intensities of CD1dHCbands immunoprecipitatedwith 42.1 and 75.10 antibodies. Bars indicate the relative
change of CD1d HC signal in samples incubated for 2 h at 37 °C in the presence of-GalCer comparedwith incubation at 4 °Cwithout lipid. Right graph shows
the ratio between the associated and free form of CD1d HC in lysates incubated with increasing concentrations of -GalCer at 37 or 4 °C without lipid. All
measureswere done by densitometrywith ImageJ software. C, CD1b-transfected C1R cells were surface biotinylated and lysedwith 0.5% Triton X-100 (pH 7.4)
(lanes 1–3) or pH 5.5 (lanes 4–12). C32 GMMwas added in increasing concentrations to samples run in lanes 7–12. Lysates were incubated for 15 h at 4 °C (lane
1 and 4), 15 h at 37 °C (lane 2 and 5), or 3 h at 37 °C followed by change in pH to 5.5 (lane 3) or 7.4 (lanes 6–12) and an additional 12-h incubation at the same
temperature. CD1d HC2m complexes were immunoprecipitated with anti-2mmAb BBM.1. Immunoprecipitates were analyzed by SDS-PAGE (15%) under
reducing conditions and immunoblottedwith streptavidin-HRP.D, quantification of intensities of bands corresponding to CD1bHC immunoprecipitatedwith
BBM.1 antibody. Bars indicate the relative change of CD1d HC signal in samples incubated at different conditions (different temperatures and pH, in presence
or absence of C32 GMM) compared with incubation at 4 °C without lipid. Intensities of bands were measured by densitometry with ImageJ software and
relative change of signal was calculated as proportion of CD1b HC signal in samples incubated at 37 °C with or without GMM to intensity of CD1b HC signal at
4 °C.
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the chances of recognition by T cells (23). On the other hand,
unloadedMHCmolecules disassemble after a few hours at 4 °C
(24). Thus, their quality control mechanism focuses on peptide
binding dependent stability.
However, the role of lipid binding by CD1molecules and the
conditions that result in stable or unstable CD1 HC2m com-
plexes are not known. Previously, an important role for pH was
identified as a factor influencing antigen loading or exchange
(25, 26), and two types of accessory molecules, microsomal tri-
glyceride transfer protein (14) and saposins were shown to facil-
itate the loading of lipids onto CD1 molecules (27–29). It is
generally assumed that self-lipid antigens are first bound to
CD1 in the ER and then foreign lipid antigens may be ex-
changed for self-lipid antigens in endosomal compartments.
Several studies have indirectly implicated lipid loading of CD1
molecules as important for CD1HC2m complex stability. For
example, decreased surface expression of CD1 in dendritic cells
was observed if microsomal triglyceride transfer protein func-
tion was impaired (15) and decreased surface recognition of
CD1a by mAb was noted in cells cultured under serum/lipid-
deficient conditions and could be reversed by adding of CD1a-
specific sulfatide antigen (16).
Here under various conditions tested, CD1 molecules were
found to be less stable than MHC class I and II molecules after
lysis at neutral pH. To examineCD1HC2m complex stability,
we developed experimental systems controlling pH, tempera-
ture, and detergent tomodel critical factors that influence com-
plex stability. CD1HC2m complexes were noted to disassem-
ble after a period of several hours at 37 °C, under conditions
whereMHC I and II complexeswere very stable. AlthoughCD1
molecules (with the exception of
hCD1d) are stable at 4 °C or room
temperature for up to 3 days (not
shown), the complexes readily dis-
sociate after cell lysis at neutral
pH when warmed to 37 °C. Because
the CD1 isoforms localize to differ-
ent endocytic compartments before
they recycle to the plasma mem-
brane, we realized that they encoun-
ter markedly different pH in each
location. This led us to investigate
the possibility that pH influences
the stability of CD1 HC2m com-
plexes at 37 °C. We found that each
CD1 isoform is optimally stable in
vitro at a different pH. CD1a and
hCD1d are maximally stable at pH
6.0, whereas the effect on CD1b is
maximal at a pH between 5.0 and
5.5. For CD1c stabilization was
noted from pH 6.5 to 5.5. Interest-
ingly, the pH at which each isoform
is maximally protected corresponds
remarkably well to the pH of the
intracellular compartment where
the particular CD1 isoform localizes
at steady state. The pH of the endo-
cytic recycling compartment, where CD1a is found, is esti-
mated between 6.0 and 6.5. Lysosomes, where CD1b localizes,
have a pH lower than 5.5. CD1c and hCD1d show a broader
intracellular distribution with some accumulation in early
endosomes and endocytic recycling compartments, as well
as in late endosomes and lysosomes. Moreover, mouse
CD1d, which contrary to its human ortholog, accumulates
almost exclusively in LAMP-1 positive compartments, is
protected across a range of lower pH, down to pH 5.0, like
hCD1b, which has a similar lysosomal intracellular localiza-
tion. Therefore, our results suggest that the physiologic pH
where CD1 molecules are normally localized stabilizes their
subunit structure. This is likely to be important because it
would be desirable for CD1 HC2m complexes to remain
intact at endosomal pH to provide a pool of molecules ready
for lipid antigen binding. We suggest that the pH-dependent
protection mechanism shown here could represent a physi-
ological stabilization mechanism for molecules awaiting
lipid binding (if empty) or lipid exchange (Fig. 7). Furthermore,
we demonstrated that specific lipid antigens can stabilize CD1
HC2m complexes in detergent lysates at pH 7.4 and 37 °C,
conditions under which they would otherwise disassemble. For
example, the hCD1d HC2m complex is protected from dis-
assembly by -GalCer in a dose-dependent manner and the
integrity of the CD1b HC2m complex is protected by
GMM (Fig. 6). Thus, successful lipid loading generates stable
CD1 HC2mlipid complexes that are no longer dependent
on endosomal pH stabilization. It is also likely that lipids
with varying affinities for binding to CD1 may correspond-
ingly provide varying levels of complex stability.
FIGURE 7. Regulation of CD1 HC2m complex stability and quality control. A, mechanisms of the CD1
stability. At neutral pH in the absence of lipid antigen the CD1 HC2m complex is unstable (upper panel). At
endosomal (acidic) pH, the CD1 HC2m complex is relatively more stable (middle panel). At endosomal pH,
lipid antigen binding or exchange is facilitated, resulting in formation of the CD1HC2m/lipid complex that is
very stable even in neutral pH (lower panel). B, quality control model based on regulation of CD1 HC2m
complex stability. In endosomal compartments, empty CD1 molecules are stabilized by low pH providing a
pool of molecules available for binding lipid antigen. CD1 molecules loaded with proper lipid antigens in
endosomal compartments form stable HC2m/lipid complexes that can traffic to the cell surface and remain
stable at neutral pH. On the other hand, CD1 molecules that are empty or loaded with poor quality lipid are
prone to dissociate at neutral pH, which would result in a shortened half-life at the cell surface. Relatively
unstable complexes are depicted in blue and stable complexes are black.
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Together, these results suggest the existence of two com-
plementary and cooperative mechanisms for stabilizing CD1
protein complexes. Namely, CD1 HC2m localized in endo-
cytic compartments at steady state are stabilized by the lower
pH encountered in these compartments. When lipid loading/
exchange occurs in endosomal compartments the CD1 HC
2mlipid complexes are further stabilized so that they are
competent to withstand the “higher” pH found at the cell
surface where T cell recognition occurs. Quality control is
inherently suggested by this model because CD1 HC2m
complexes that are not stabilized by lipid antigen binding
would be predicted to disassemble andhave a shorter half-life at
the cell surface (Fig. 7).
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